NEW YORK – Enzo Biochem said on Tuesday that it has partnered with CLX Health to help provide rapid COVID-19 PCR testing for international travel.
Enzo's test processing locations in New York and New Jersey will now be added to a network of providers using CLX Health's cloud-based TrustAssure platform.
The TrustAssure platform enables travelers to schedule COVID-19 testing at locations convenient to them, receive their results, and transmit compliance status to their airline.
Patients can now schedule testing through the TrustAssure platform at Enzo's locations throughout New York and New Jersey, and tests are processed at the firm's clinical lab using its proprietary GenFlex platform, according to Enzo.
"The [TrustAssure] mobile experience handles the necessary physician authorizations and delivers results directly to the customer," said Enzo's CEO Elazar Rabbani in a statement.
Bob Fluery, global lab director for CLX Health, said that the TrustAssure platform has a directory of more than 15,000 COVID-19 testing sites worldwide, including in 81 countries. Enzo's testing sites in New York and New Jersey will help "meet demand for testing in this important region as travel increases in the coming months," he said.
Enzo received approval in New York State last year for sexually transmitted infection screening on the GenFlex platform. The firm was granted Emergency Use Authorization from the US Food and Drug Administration for a COVID-19 testing sample collection kit, called Ampicollect, in April.